| Literature DB >> 30355342 |
Tülin Güven Gökmen1,2, Yıldız Kalayci3, Akgün Yaman4, Fatih Köksal4.
Abstract
BACKGROUND: Rapid detection of sources and transmission routes by molecular methods provides key data for risk management of methicillin-resistant Staphylococcus aureus-induced infections acquired in both the community and hospitals. This study aimed to determine the clonal relationship of methicillin-resistant S. aureus strains isolated from our hospital by pulsed-field gel electrophoresis (PFGE) and Staphylococcal protein A (spa) typing methods and to identify the predominant clones in Cukurova Region, Turkey.Entities:
Keywords: Epidemiology; MRSA; PFGE; Protein a; spa typing
Mesh:
Substances:
Year: 2018 PMID: 30355342 PMCID: PMC6201486 DOI: 10.1186/s12866-018-1305-6
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Study Patients Characteristics and Epidemiologic Classification
| Characteristics | percent | |
|---|---|---|
| Sex: F/M | 23/52 | 30.6/69.4 |
| Age Distribution: | ||
| Median/IQR | 34/0–85 | – |
| Inpatients/Outpatients | 64/11 | 85.3/14.7 |
| Samples | ||
| Wound IP/OP | 20/10 | 26.7/13.3 |
| Tracheal aspirate IP/OP | 31/− | 41.3/− |
| Blood IP/OP | 11/− | 14.7/− |
| Urine IP/OP | 2/1 | 2.7/1.3 |
F Female, M Male, IQR Interquartile range, IP Inpatients, OP Outpatients
Distribution of isolates to hospital units
| Unit | Isolates number (%) |
|---|---|
| Pediatric Intensive Care Unit | 10 (13%) |
| Reanimation Intensive Care Unit | 10 (13%) |
| Internal Medicine Intensive Care Unit | 5 (6.7%) |
| Chest Disease Unit | 4 (5.3%) |
| Infectious Disease Unit | 4 (5.3%) |
| Dermatology Unit | 4 (5.3%) |
| Burn Unit | 3 (4%) |
| Pediatric Oncology Unit | 2 (2.7%) |
| Pediatric Haematology Unit | 2 (2.7%) |
| Pediatric İnfectious Disease Unit | 2 (2.7%) |
| Pediatric 2 Unit | 2 (2.7%) |
| Nephrology Unit | 2 (2.7%) |
| Urology Unit | 2 (2.7%) |
| Neurology Intensive Care Unit | 2 (2.7%) |
| Endocrinology Unit | 2 (2.7%) |
| Plastic and Reconstructive Surgery Unit | 2 (2.7%) |
| Haematology Unit | 2 (2.7%) |
| Neonatal Intensive Care Unit | 1 (1.3%) |
| Pedatric Allergy and Immunology Unit | 1 (1.3%) |
| Neurosurgery Unit | 1 (1.3%) |
| Ortopedics and Traumatology Unit | 1 (1.3%) |
| Gynecology and obstetrics unit | 1 (1.3%) |
| General Surgery Unit | 1 (1.3%) |
| Pediatric İnfectious Disease Unit 2 | 1 (1.3%) |
| Oncology Unit | 1 (1.3%) |
| Ophtalmology Unit | 1 (1.3%) |
| Pediatric Gastroenterology Unit | 1 (1.3%) |
| Pediatric Surgery Unit | 1 (1.3%) |
| Neurology Unit | 1 (1.3%) |
| Urology Unit 2 | 1 (1.3%) |
| Neurosurgery Unit | 1 (1.3%) |
| Pediatrics Cardiovascular surgery Unit | 1 (1.3%) |
| Total | 75 |
Antibiotic resistance of MRSA isolates
| Antibiotics | CIP | DA | E | FOS | FA | CN | LZD | MOX | RA | TEI | TE | TIG | SXT | VA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resistant strains number | 39 | 43 | 46 | 26 | 5 | 36 | – | 32 | 39 | – | 47 | – | 13 | – |
| % | 52 | 57.3 | 61.3 | 34.6 | 6.7 | 48 | 0 | 42.7 | 52 | 0 | 62.6 | 0 | 17.3 | 0 |
CIP Ciprofloxacin, DA Clindamycin, E Erythromycin, Fusidic acid, FOS Fosfomycin, CN Gentamycin, IPM Imipenem, OX Oxacillin, LZD Linezolid, RA Rifampin, TEI Teicoplanin TE Tetracycline, TIG Tigecycline, SXT Trimethoprim-sulfametaxazole, VA Vancomycin
Distribution of test isolates by their spa types according to samples and spa types
| Spa types | PFGE types | Outpatients | Inpatients | Samples Number (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TA | Wound | Blood | Urine | TA | Wound | Blood | Urine | |||
| t030 | A | – | – | – | – | 11 | 3 | 5 | 1 | 31 (41.3%) |
| B | – | – | – | 1 | 8 | 1 | – | – | ||
| C | – | – | – | 1 | ||||||
| t223 | G | – | – | – | – | 1 | 3 | 1 | 1 | 9 (12%) |
| H | – | – | – | – | – | – | 2 | – | ||
| J | – | – | – | – | 1 | – | – | – | ||
| t127 | B | – | 2 | – | – | 3 | – | – | – | 7 (9.3%) |
| F | – | – | – | – | 2 | – | – | – | ||
| t037 | B | – | – | – | – | – | 1 | – | – | 6 (8%) |
| D | – | – | – | – | – | 1 | 2 | – | ||
| G | – | – | – | – | – | 1 | 1 | – | ||
| t005 | G | – | 2 | – | – | – | 1 | – | – | 4 (5. 3%) |
| M | – | 1 | – | – | – | – | – | – | ||
| t002 | B | – | 1 | – | – | – | 1 | – | – | 2 (2.7%) |
| t267 | G | – | 1 | – | – | – | – | – | – | 2 (2.7%) |
| N | – | – | – | – | – | 1 | – | – | ||
| t008 | B | – | – | – | – | – | 2 | – | – | 2 (2.7%) |
| t016 | B | – | – | – | – | – | 2 | – | – | 2 (2.7%) |
| t790 | B | – | – | – | – | 1 | 1 | – | – | 2 (2.7%) |
| t304 | C | – | 1 | – | – | – | – | – | – | 1 (1.3%) |
| t459 | D | – | – | – | – | 1 | – | – | – | 1 (1.3%) |
| t359 | K | – | – | – | – | – | 1 | – | – | 1 (1.3%) |
| t311 | A | – | – | – | – | – | 1 | – | – | 1 (1.3%) |
| t091 | G | – | 1 | – | – | – | – | – | – | 1 (1.3%) |
| t7576 | A | – | – | – | – | 1 | – | – | – | 1 (1.3%) |
| t2816 | N | 1 | – | – | – | – | – | – | 1 (1.3%) | |
| t4565 | M | – | – | – | – | – | 1 | – | – | 1 (1.3%) |
| Total | 11 | 64 | 75 (100%) | |||||||
TA Tracheal aspirate
Comparison of S.aureus strains with PFGE and spa typing
Fig. 1Distribution of spa clonal complexes (BURP analysis)